- Detecting a neoplastic clone associated with the common chromosome anomalies seen in patients with myelodysplastic syndromes or other myeloid malignancies.
- Evaluating specimens in which standard cytogenetic analysis is unsuccesful.
- Identifying and tracking known chromosome anomalies in patients with myeloid malignancies and tracking response to therapy.